相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The variant organic cation transporter 2 (OCT2)-T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin
Zahra Kashi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study
Abdolkarim Mahrooz et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2015)
Disposition of metformin: Variability due to polymorphisms of organic cation transporters
Oliver Zolk
ANNALS OF MEDICINE (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Treating Mixed Hyperlipidemia and the Atherogenic Lipid Phenotype for Prevention of Cardiovascular Events
Melvyn Rubenfire et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Mechanisms of metformin action on glucose transport and metabolism in human adipocytes
Jean Grisouard et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Racial differences in the association between body fat distribution and lipid profiles among reproductive-age women
G. M. M. Hosain et al.
DIABETES & METABOLISM (2010)
The Effect of Oral Antidiabetic Agents on A1C Levels
Diana Sherifali et al.
DIABETES CARE (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Metformin - the gold standard in type 2 diabetes: what does the evidence tell us?
E. Bosi
DIABETES OBESITY & METABOLISM (2009)
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver
Anne T. Nies et al.
HEPATOLOGY (2009)
Polymorphism in human organic cation transporters and metformin action
Hiroshi Takane et al.
PHARMACOGENOMICS (2008)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
Eriko Shikata et al.
JOURNAL OF HUMAN GENETICS (2007)
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials
Joao Costa et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
R Kerb
CANCER LETTERS (2006)
Pharmacogenomics of human OATP transporters
J König et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes
JB Buse et al.
DIABETES OBESITY & METABOLISM (2004)
Relationship between serum lipoprotein ratios and insulin resistance in obesity
A Brehm et al.
CLINICAL CHEMISTRY (2004)
One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes
M Hanefeld et al.
DIABETES CARE (2004)
分享论文
